Funded Tech Companies
Umecrine Cognition
Wondering who invested in Umecrine Cognition? Karolinska invested in this biopharmaceutical company.
Company Overview
Company Name
Umecrine Cognition
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Nanna Svartz väg 6A
Solna, 171 65
Sweden
Solna, 171 65
Sweden
Phone
Website
Email Address
Company Background Information
Overview
Umecrine Cognition is developing a completely new type of drug for neurological disorders in the brain that can occur as a result of a number of underlying diseases and lead to severely reduced cognition and alertness. The results from an internationally recognized clinical phase 2 study indicate that the company's most advanced drug candidate, golexanolone, improves brain signaling and cognition and alertness in patients with hepatic encephalopathy.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/14/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Viktor Drvota
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs